FI842976A - Foerfarande foer framstaellning av farmaceutiskt aktiva aminopyrimidinonderivat. - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva aminopyrimidinonderivat. Download PDF

Info

Publication number
FI842976A
FI842976A FI842976A FI842976A FI842976A FI 842976 A FI842976 A FI 842976A FI 842976 A FI842976 A FI 842976A FI 842976 A FI842976 A FI 842976A FI 842976 A FI842976 A FI 842976A
Authority
FI
Finland
Prior art keywords
aminopyrimidinonderivat
farmaceutiskt
aktiva
hydrogen
foerfarande foer
Prior art date
Application number
FI842976A
Other languages
English (en)
Other versions
FI842976A0 (fi
Inventor
Thomas Henry Brown
David Tuddenham
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI842976A0 publication Critical patent/FI842976A0/fi
Publication of FI842976A publication Critical patent/FI842976A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI842976A 1983-07-29 1984-07-26 Foerfarande foer framstaellning av farmaceutiskt aktiva aminopyrimidinonderivat. FI842976A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320505A GB8320505D0 (en) 1983-07-29 1983-07-29 Chemical compounds

Publications (2)

Publication Number Publication Date
FI842976A0 FI842976A0 (fi) 1984-07-26
FI842976A true FI842976A (fi) 1985-01-30

Family

ID=10546495

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842976A FI842976A (fi) 1983-07-29 1984-07-26 Foerfarande foer framstaellning av farmaceutiskt aktiva aminopyrimidinonderivat.

Country Status (21)

Country Link
EP (1) EP0134096B1 (fi)
JP (1) JPS6051179A (fi)
KR (1) KR850001174A (fi)
AT (1) ATE40552T1 (fi)
AU (1) AU564650B2 (fi)
CA (1) CA1261831A (fi)
CS (1) CS244448B2 (fi)
DD (1) DD216933A5 (fi)
DE (1) DE3476541D1 (fi)
DK (1) DK368284A (fi)
ES (1) ES534620A0 (fi)
FI (1) FI842976A (fi)
GB (1) GB8320505D0 (fi)
GR (1) GR82226B (fi)
HU (1) HUT34743A (fi)
IL (1) IL72491A0 (fi)
JO (1) JO1327B1 (fi)
NO (1) NO843043L (fi)
PT (1) PT78977B (fi)
ZA (1) ZA845820B (fi)
ZW (1) ZW11584A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
CN1972914A (zh) 2004-03-31 2007-05-30 詹森药业有限公司 作为组胺h3受体配合体的非咪唑杂环化合物
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CN105712977B (zh) 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (fi) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DE3476541D1 (de) 1989-03-09
DD216933A5 (de) 1985-01-02
EP0134096A2 (en) 1985-03-13
DK368284A (da) 1985-01-30
EP0134096B1 (en) 1989-02-01
CA1261831A (en) 1989-09-26
EP0134096A3 (en) 1985-12-18
ES8600254A1 (es) 1985-09-16
JO1327B1 (en) 1986-11-30
CS581084A2 (en) 1985-08-15
NO843043L (no) 1985-01-30
IL72491A0 (en) 1984-11-30
AU564650B2 (en) 1987-08-20
PT78977B (en) 1986-06-05
ZW11584A1 (en) 1985-04-17
CS244448B2 (en) 1986-07-17
HUT34743A (en) 1985-04-28
PT78977A (en) 1984-08-01
GR82226B (fi) 1984-12-13
DK368284D0 (da) 1984-07-27
ATE40552T1 (de) 1989-02-15
ZA845820B (en) 1985-06-26
GB8320505D0 (en) 1983-09-01
AU3099184A (en) 1985-01-31
FI842976A0 (fi) 1984-07-26
JPS6051179A (ja) 1985-03-22
ES534620A0 (es) 1985-09-16
KR850001174A (ko) 1985-03-16

Similar Documents

Publication Publication Date Title
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
NO894349L (no) Tienopyridin-type mevalonolaktoner.
FI842976A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva aminopyrimidinonderivat.
ATE67757T1 (de) Pyrimidinverbindungen.
FI845095L (fi) Aminoimidazolonderivat saosom histamin-h2-antagonister.
SE8303913D0 (sv) Heterocykliska foreningar
EP0143630A3 (en) Chemical compounds
ES8602764A1 (es) Un procedimiento para preparar derivados de tiadiazina
IE832323L (en) Dioxocyclobutenes
DE3070032D1 (en) Aminoalkyl benzofuran derivatives, their production and compositions containing them
ATE5724T1 (de) Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
TH1858A (th) กรรมวิธีทางเคมี

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITH KLINE & FRENCH LABORATORIES